Results 251 to 260 of about 435,208 (390)

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Incremental Prognostic Value of Cystatin C-Based Estimated Glomerular Filtration Rate in Patients With Acute Coronary Syndrome. [PDF]

Rev Cardiovasc Med
Chen Q, Li Y, Chen X, He H, Xie Y, Xu Y, Cai Y, Ye T, Gao Y, Xiong S, Cai L, Zheng J.   +11 more
europepmc   +1 more source

The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate [PDF]

, 2006
Jarir At Thobari, Ron T. Gansevoort, Sipke T. Visser, Paul E. de Jong, Lolkje T.W. de Jong‐van den Berg   +4 more
openalex   +1 more source

Glomerular Filtration Rate [PDF]

, 2020
openaire   +1 more source

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Drug Exposure in Chronic Kidney Disease: It Is Not Just About the Glomerular Filtration Rate. [PDF]

Fundam Clin Pharmacol
Liabeuf S, Berdougo-Tritz J, Augey L, Mbarek A, Jadoul M, Deray G, Massy ZA.   +6 more
europepmc   +1 more source

Contribution of the glomerular filtration rate slope to the kidney hierarchical composite endpoint

Dustin J. Little, Niels Jongs, Meike Brinker, Samvel B. Gasparyan, Patrick Schloemer, Hiddo J.L. Heerspink   +5 more
openalex   +1 more source

N‐terminal pro‐brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi, Masaomi Nangaku, Tadashi Sofue, Tatsuo Kagimura, Ichiei Narita   +4 more
wiley   +1 more source

Hyperhomocysteinemia and its association with decreased glomerular filtration rate in patients with chronic kidney disease: a comprehensive meta-analysis. [PDF]

PeerJ
Chen W, Liang X, Liang G, Zhao X, Wang J, Jiang Q.   +5 more
europepmc   +1 more source

Impact of Arteriovenous fistula creation on estimated glomerular filtration rate decline in Predialysis patients [PDF]

, 2019
Valérie Bénard, Maude Pichette, Jean‐Philippe Lafrance, Naoual Elftouh, Vincent Pichette, Louis‐Philippe Laurin, Annie‐Claire Nadeau‐Fredette   +6 more
openalex   +1 more source